1. Home
  2. QUAD vs BNTC Comparison

QUAD vs BNTC Comparison

Compare QUAD & BNTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Quad Graphics Inc

QUAD

Quad Graphics Inc

HOLD

Current Price

$9.64

Market Cap

438.3M

ML Signal

HOLD

Logo Benitec Biopharma Inc.

BNTC

Benitec Biopharma Inc.

HOLD

Current Price

$11.00

Market Cap

396.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
QUAD
BNTC
Founded
1971
1995
Country
United States
United States
Employees
N/A
24
Industry
Publishing
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
438.3M
396.3M
IPO Year
2010
2020

Fundamental Metrics

Financial Performance
Metric
QUAD
BNTC
Price
$9.64
$11.00
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
3
Target Price
$9.93
$27.67
AVG Volume (30 Days)
341.3K
100.1K
Earning Date
04-28-2026
05-14-2026
Dividend Yield
5.71%
N/A
EPS Growth
150.47
6.67
EPS
0.13
N/A
Revenue
$2,419,900,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$73.08
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.12
$9.85
52 Week High
$11.15
$16.76

Technical Indicators

Market Signals
Indicator
QUAD
BNTC
Relative Strength Index (RSI) 41.62 36.36
Support Level $7.15 $10.04
Resistance Level $11.01 $14.14
Average True Range (ATR) 0.37 0.66
MACD -0.12 -0.16
Stochastic Oscillator 17.18 14.61

Price Performance

Historical Comparison
QUAD
BNTC

About QUAD Quad Graphics Inc

Quad/Graphics Inc provides print and marketing services to help customers market their products, services, and contents. The company operates in the commercial segment of the printing industry. It operates through three divisions. The United States print and related services segment consists of the company's American operations. Besides the complete set of print and marketing solutions, this segment also manufactures ink. The international segment includes the company's printing business in Europe and Latin America and others countries. The corporate segment is engaged in the general and administrative activities as well as associated costs. The company almost generates all its revenue from the American domestic market..

About BNTC Benitec Biopharma Inc.

Benitec Biopharma Inc is a clinical-stage biotechnology company focused on advancing novel genetic medicines. Its technology could provide a one-shot cure for a wide range of diseases that require strict, ongoing treatment regimens or have no effective treatment or only palliative care options. The Company is developing a silence-and-replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life-threatening genetic disorder. The company has a single operating segment, which is the business of discovery and development of therapeutic agents for the treatment of genetic disorders.

Share on Social Networks: